![[Lys3] - Bombesin<br>Pyr - QKLGNQWAVGHLM - NH2](/media/com_eshop/products/resized/prod_150x150-500x500.png "[Lys3] - Bombesin<br>Pyr - QKLGNQWAVGHLM - NH2")
Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
[Lys3] - Bombesin
Pyr - QKLGNQWAVGHLM - NH2
| Overview | |
|---|---|
| Description | PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma. |
| Sequence | Pyr-QKLGNQWAVGHLM-NH2 |
| Sequence (3 Letter) | Pyr - Gln - Lys - Leu - Gly - Asn - Gln - Trp - Ala - Val - Gly - His - Leu - Met - NH2 |
| Molecular Weight | 1591.9 |
| Properties | |
| Purity | % Peak Area By HPLC ≥ 95% |
| Storage | -20 °C |
Ref: Chen, J. et al. J. Nucl. Med. 45,1390 (2004); Chen, X. et al. J. Nucl. Med. 45, (1390); Baidoo, K. et al. Bioconjug. Chem. 9, 218 (1998).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.